BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36809213)

  • 1. Added Value of Pelvic CT after Treatment of HCC.
    Yeom A; Chi SA; Song KD
    Radiology; 2023 May; 307(3):e222314. PubMed ID: 36809213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative PET-CT is useful for predicting recurrent extrahepatic metastasis of hepatocellular carcinoma after resection.
    Morio K; Kawaoka T; Aikata H; Namba M; Uchikawa S; Kodama K; Ohya K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Imamura M; Nakamura Y; Akagi M; Awai K; Kobayashi T; Ohdan H; Chayama K
    Eur J Radiol; 2020 Mar; 124():108828. PubMed ID: 31955034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors.
    Kanda M; Tateishi R; Yoshida H; Sato T; Masuzaki R; Ohki T; Imamura J; Goto T; Yoshida H; Hamamura K; Obi S; Kanai F; Shiina S; Omata M
    Liver Int; 2008 Nov; 28(9):1256-63. PubMed ID: 18710423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrahepatic metastases of hepatocellular carcinoma.
    Katyal S; Oliver JH; Peterson MS; Ferris JV; Carr BS; Baron RL
    Radiology; 2000 Sep; 216(3):698-703. PubMed ID: 10966697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluation.
    Bae HM; Lee JH; Yoon JH; Kim YJ; Heo DS; Lee HS
    BMC Cancer; 2011 Oct; 11():435. PubMed ID: 21985636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic imaging for guidance of curative treatment of isolated pelvic implantation metastasis after resection of spontaneously ruptured hepatocellular carcinoma: A case report.
    Hao B; Guo W; Luo NN; Fu H; Chen HJ; Zhao L; Wu H; Sun L
    World J Gastroenterol; 2016 Nov; 22(41):9242-9246. PubMed ID: 27895412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma.
    Kato H; Yoshida H; Taniguch H; Nomura R; Sato K; Suzuki I; Nakata R
    World J Gastroenterol; 2015 Dec; 21(46):13101-12. PubMed ID: 26673627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment platelet count early predicts extrahepatic metastasis of human hepatoma.
    Lee CH; Lin YJ; Lin CC; Yen CL; Shen CH; Chang CJ; Hsieh SY
    Liver Int; 2015 Oct; 35(10):2327-36. PubMed ID: 25752212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of intrahepatic tumor control in the prognosis of patients with hepatocellular carcinoma and extrahepatic metastases.
    Jung SM; Jang JW; You CR; Yoo SH; Kwon JH; Bae SH; Choi JY; Yoon SK; Chung KW; Kay CS; Jung HS
    J Gastroenterol Hepatol; 2012 Apr; 27(4):684-9. PubMed ID: 21916984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis.
    Xia F; Wu L; Lau WY; Li G; Huan H; Qian C; Ma K; Bie P
    PLoS One; 2014; 9(4):e95889. PubMed ID: 24760012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of [
    John BV; Aubuchon S; Dahman B; Konjeti VR; Heuman D; Hubert J; Thomas S; Deng Y; Solomon C; Sundaram LT; Love E; Singal AG; Tatum JL
    Liver Transpl; 2020 Jun; 26(6):774-784. PubMed ID: 32128966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
    Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
    Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma presenting as primary extrahepatic mass on CT.
    Longmaid HE; Seltzer SE; Costello P; Gordon P
    AJR Am J Roentgenol; 1986 May; 146(5):1005-9. PubMed ID: 3008540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
    Mikami S; Tateishi R; Akahane M; Asaoka Y; Kondo Y; Goto T; Shiina S; Yoshida H; Koike K
    J Vasc Interv Radiol; 2012 Oct; 23(10):1269-75. PubMed ID: 22999746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography/computed tomography scan.
    Lee JE; Jang JY; Jeong SW; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Jin SY; Choi DL
    World J Gastroenterol; 2012 Jun; 18(23):2979-87. PubMed ID: 22736922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.
    Kim HD; Lim YS; Han S; An J; Kim GA; Kim SY; Lee SJ; Won HJ; Byun JH
    Gastroenterology; 2015 Jun; 148(7):1371-82. PubMed ID: 25733098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
    Chen Z; Liang H; Zhang X; Wang X; Chen W; Shi X; Yi C; Rao L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1615-9. PubMed ID: 23174588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings.
    Nagaoka S; Itano S; Ishibashi M; Torimura T; Baba K; Akiyoshi J; Kurogi J; Matsugaki S; Inoue K; Tajiri N; Takada A; Ando E; Kuromatsu R; Kaida H; Kurogi M; Koga H; Kumashiro R; Hayabuchi N; Kojiro M; Sata M
    Liver Int; 2006 Sep; 26(7):781-8. PubMed ID: 16911459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.
    Kikuchi L; Menezes M; Chagas AL; Tani CM; Alencar RS; Diniz MA; Alves VA; D'Albuquerque LA; Carrilho FJ
    World J Gastroenterol; 2014 Feb; 20(6):1585-93. PubMed ID: 24587635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.